Filter
2820
Filtered Results: 2820
Text search:
Drug
Resistance
Featured
Recommendations
300
New Publications
745
Language
Document type
No document type
1629
Studies & Reports
424
Guidelines
421
Manuals
119
Strategic & Response Plan
90
Fact sheets
54
Training Material
41
Situation Updates
15
Infographics
12
Online Courses
5
Resource Platforms
4
Brochures
3
Videos
3
Countries / Regions
India
153
South Africa
80
Kenya
79
Global
76
Western and Central Europe
74
Ethiopia
60
Uganda
51
Nepal
48
Tanzania
48
Eastern Europe
47
Africa
42
Zambia
40
Nigeria
39
Liberia
37
Sierra Leone
34
Latin America and the Carribbean
34
Malawi
32
Philippines
31
Myanmar / Burma
30
Ghana
29
Bangladesh
28
Rwanda
27
Asia
24
Namibia
24
Lesotho
22
Cambodia
22
South–East Asia Region
21
Zimbabwe
20
Indonesia
19
Ukraine
18
Russia
18
Senegal
17
Botswana
14
Congo, Democratic Republic of
13
Mozambique
12
Colombia
11
Cameroon
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Haiti
6
Benin
5
Laos
5
Guinea
5
Vietnam
5
Georgia
5
China
4
Peru
4
Western Pacific Region
4
Brazil
4
Sudan
4
Iraq
4
North Macedonia
3
El Salvador
3
Iran
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Yemen
2
Mali
2
Libya
2
Ecuador
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Guinea-Bissau
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
995
Clinical Guidelines
310
Public Health
127
Women & Child Health
81
Key Resources
72
Capacity Building
38
Pharmacy & Technologies
37
Annual Report MEDBOX
1
Toolboxes
TB
505
HIV
343
AMR
328
NTDs
119
Mental Health
111
COVID-19
94
Pharmacy
75
Rapid Response
61
Caregiver
49
Planetary Health
48
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Polio
17
Conflict
14
Cholera
13
Health Financing Toolbox
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Malaria
1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector. The proposed approach recognizes and aims to address the challenges and health system barriers people face when accessing health services to prev...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collection, transport, culture, anti-microbial drug suscept...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
Antimicrobial resistance (AMR) is one of the world’s top 10 public health threats. The World Health Organization (WHO) in the African Region, using the Antimicrobial Stewardship assessment tool, has assessed Member States progress on strengthening national capacity need for effective implementatio...
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewardship activities focus on measuring and improving ...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
